{"id":"W4391519272","doi":"10.1093/ecco-jcc/jjae013","title":"Safety of Ustekinumab in Inflammatory Bowel Disease: Pooled Safety Analysis Through 5 Years in Crohn’s Disease and 4 Years in Ulcerative Colitis","year":2024,"lang":"en","type":"article","venue":"Journal of Crohn s and Colitis","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":38,"is_retracted":false,"has_abstract":true,"ca_institutions":"Western University","funders":"Janssen Research and Development; Allergan; Bausch Health; Celltrion; Boston Pharmaceuticals; BeiGene; Genentech; Janssen Scientific Affairs; Janssen Pharmaceuticals; Gilead Sciences; Mylan; Celgene; Biogen; GlaxoSmithKline; Tillotts Pharma; Seres Therapeutics; Amgen; Pfizer; Kiniksa Pharmaceuticals; Shire; AstraZeneca; Eli Lilly and Company; Bristol-Myers Squibb","keywords":"Ustekinumab; Medicine; Internal medicine; Adverse effect; Inflammatory bowel disease; Placebo; Crohn's disease; Ulcerative colitis; Surgery; Infliximab; Disease; Pathology","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004681206,0.0001918124,0.0003880702,0.0003763364,0.00002823692,0.00007495147,0.0001353705,0.0001183726,0.00005890353],"category_scores_gemma":[0.0001141017,0.0002013595,0.0001981891,0.0003218928,0.000193752,0.00005415701,0.0001050344,0.000224341,9.16598e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001112323,"about_ca_system_score_gemma":0.0005356633,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00009278918,"about_ca_topic_score_gemma":0.001547515,"domain_scores_codex":[0.9980885,0.0002431225,0.0008172595,0.000312203,0.0002522783,0.0002866528],"domain_scores_gemma":[0.9991931,0.00004408474,0.0001914805,0.0002061367,0.00009520739,0.0002700089],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.06208557,0.0004952649,0.8574777,0.001189177,0.001628594,0.05354602,0.003887147,0.003484725,0.0003722081,0.005255283,0.0006855782,0.009892754],"study_design_scores_gemma":[0.001677149,0.00004887865,0.9945021,0.0003414054,0.0002435707,0.00001639124,0.0002925851,0.000364195,0.00002539602,0.0006750045,0.001607847,0.0002054513],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9954891,0.00348089,0.00004600718,0.0001238884,0.00008725826,0.0002571704,0.0003489175,0.000003573512,0.0001631957],"genre_scores_gemma":[0.9970153,0.002532512,0.00006140675,0.0001004489,0.0001018002,0.00001395491,0.00003341866,0.00002173831,0.0001194286],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1370244,"threshold_uncertainty_score":0.8211201,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.005089426090467071,"score_gpt":0.243725997318994,"score_spread":0.2386365712285269,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}